Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) provided an update on its activities directed toward the resubmission of its Biologics License Application ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE